CONTENTS

        Chapters
  1. Background
  2. IUD Performance
  3. Insertion
  4. Removal
  5. Infection
  6. Worldwide Use
  7. IUDs in Family Planning Programs
Published by the Population Information Program, Center for Communication Programs, The Johns Hopkins School of Public Health, 111 Market Place, Suite 310, Baltimore, Maryland 21202-4012, USA

Volume XXIII, Number 5
December 1995
Public Health Organizations
Reaffirm Support for IUDs
When the US pharmaceutical companies stopped selling IUDs, national and international health and family planning organizations protested. All reaffirmed their support for IUDs and recommended that they be made widely available (2, 6, 8, 159, 161, 274). A World Health Organization (WHO) Scientific Group, convened in 1986 to review the safety of IUDs, concluded, The use of IUDs in both developed and developing countries should continue to be supported as a reliable and safe method of reversible fertility regulation (437). More recently, in 1995 the International Medical Advisory Panel of the International Planned Parenthood Federation (IPPF) described the IUD as an effective and safe method of contraception for properly screened women (600). The Panel noted that:

Most newer IUDs have now been studied in a large number of women for a long period of time. These studies demonstrate that these IUDs are highly effective and very safe among women at low risk of STDs.

All donor agencies continue to provide IUDs in response to requests from governments and private voluntary family planning agencies.


Previous | Next
Top of Page | Table of Contents

111 Market Place, Suite 310, Baltimore, MD 21202, USA
Phone: (410) 659.6300/Fax: (410) 659.6266/E-mail: Poprepts@jhuccp.org

Population Reports